Godavari Biorefineries Share Price
240.80-4.45 (-1.81%)
-15.78% past 1 Year
News
Godavari Biorefineries receives European patent for anti cancer drug process
Equity
GODAVARIB
Godavari Biorefineries posts lower Q1 EBITDA and margin
Equity
GODAVARIB
Godavari Biorefineries reports higher Q1 revenue year on year
Equity
GODAVARIB
Godavari Biorefineries reports wider Q1 standalone net loss year-on-year
Equity
GODAVARIB
Godavari Biorefineries opens 200 KLPD corn based distillery at Sameerwadi
Equity
GODAVARIB
Godavari Biorefineries starts 200 KLPD corn distillery at Sameerwadi
Equity
GODAVARIB
Godavari Biorefineries secures Japanese patent for novel cancer treatment compound
Equity
GODAVARIB
Godavari Biorefineries posts weaker Q4 EBITDA and margin on year-ago basis
Equity
GODAVARIB
Godavari Biorefineries Q4 FY results show lower profit and softer revenue YoY
Equity
GODAVARIB
Godavari Biorefineries Announces Plans to Triple EBITDA by 2029 with Rs 325 Cr Capex.
Equity
GODAVARIB
Godavari Biorefineries Secures Patent in Japan for Virus Treatment Molecule.
Equity
GODAVARIB
Godavari Biorefineries Q3 FY26 Results: EBITDA Growth Amid Profitability Challenges
Equity
GODAVARIB
Godavari Biorefineries Reports Strong Q3 FY26 Results with Profitability Growth.
Equity
GODAVARIB
Godavari Biorefineries partners with Synthomer for sustainable monomer alternatives
Equity
GODAVARIB
Godavari Biorefineries’ Sathgen Therapeutics sets up new US step-down subsidiary
Equity
GODAVARIB
Godavari Biorefineries secures patent for anti-cancer stem cell compounds
Broader Market
GODAVARIB
Godavari Biorefineries secures US patent for novel anti-cancer compounds
Equity
GODAVARIB
Godavari Biorefineries Q2 FY26: Sequential Revenue Decline, Net Loss Widens YoY
Equity
GODAVARIB
Godavari Biorefineries wins ICC Award for efficient CO2-to-DME green fuel technology partnership
Equity
GODAVARIB
Godavari Biorefineries launches CO?-to-DME project with ICT Mumbai, wins ICC–K.V. Mariwala Award.
Equity
GODAVARIB